Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

Canada — Canada s Drug Agency

Tracked across 2 events · 13 articles · First seen Jul 06, 2026 · Last active Jul 16, 2026

Sentiment
0
Attention
3
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 0
Regulatory
Impact: Issued updated recommendation to fund lecanemab for early-stage Alzheimer's, reversing earlier decision.
Jul 16, 2026 · 7 articles
3 0
Business
Impact: CDA-AMC issued a positive reimbursement recommendation for ALYFTREK in December 2025, which preceded the LOI.
Jul 06, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Canada — Canada s Drug Agency live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.